Central Corneal Pseudomicrocysts Resultant from Belantamab Mafodotin Therapy: A Case Report
Belantamab mafodotin use carrires a significant risk of ocular toxicity. Corneal pseudomicrocysts are dose-dependent and can impact visual outcomes.
Read More
